Blood test score may flag High-Risk esophageal surgery patients
NCT ID NCT07761975
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study looks at whether a simple score calculated from routine blood tests—measuring hemoglobin, albumin, lymphocytes, and platelets (the HALP score)—can help predict complications after surgery to remove esophageal cancer. Researchers will track how this score changes before and after surgery in 131 adults and see if it relates to problems like leaks, intensive care needs, or longer hospital stays. The goal is to find out if this easy-to-measure score could serve as a warning sign for patients who may need extra care during recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Perioperative HALP score assessment using routine blood tests
- What this could lead to
- If the HALP score proves useful, it could become a simple, low-cost tool to help doctors identify patients at higher risk of complications after esophageal cancer surgery, potentially improving recovery planning.
- What could go wrong
- This is a retrospective observational study, so it can only show associations, not cause and effect. The HALP score may not reliably predict outcomes in all patients or settings, and its clinical usefulness remains uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Basaksehir Cam and Sakura City Hospital
Istanbul, Istanbul, 34480, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- A simple sensor on the back could warn of kidney danger during heart surgery
- CT scans may predict breast reconstruction flap failure
- Can surgery for stomach or esophageal cancer cloud the mind?
- Virtual patients could revolutionize cancer drug testing